Clinical Trials | June 13, 2026
Ryvu advances romaciclib program as FDA clears AML trial expansion
The regulatory decision follows promising results from RIVER-81
The regulatory decision follows promising results from RIVER-81
Approval is based on results from the phase 3 OASIS 4 clinical trial
Two-year collaboration aims to strengthen primary healthcare systems, generate real-world evidence, and support responsible adoption of AI and digital health technologies across South-East Asia
Recognition highlights the hospital network’s decade-long investment in analytics and AI-driven healthcare, supporting improved outcomes, efficiency, and affordability.
The milestone, announced from Wilmington, Delaware, is powered through additional Renewable Energy Certificates (RECs) and backed by US-sourced renewable generation
Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion
The union minister spoke at the 2nd Pharma Summit & Awards 2026 organised by ASSOCHAM in New Delhi
Indian Pharmacopoeia Commission hosts scientific conclave to brainstorm on strengthening pharmaceutical quality and compliance
Union Minister inaugurated a DST-funded Central Instrumentation Facility and three new research clusters focused on advanced materials, clean energy, and healthcare at IIT Gandhinagar
Company experts to participate in eight sessions covering AI-powered clinical development, regulatory innovation, oncology research, and patient engagement
Subscribe To Our Newsletter & Stay Updated
